Loading...
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
BACKGROUND: The PORTEC-3 trial investigated the benefit of combined adjuvant chemotherapy and radiotherapy versus pelvic radiotherapy alone for women with high-risk endometrial cancer. We updated the analysis to investigate patterns of recurrence and did a post-hoc survival analysis. METHODS: In the...
Na minha lista:
| Udgivet i: | Lancet Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lancet Pub. Group
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6722042/ https://ncbi.nlm.nih.gov/pubmed/31345626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(19)30395-X |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|